This is a prospective study to compare the safety and efficacy of treating small aneurysms.
Mechanical thrombectomy, the mechanical removal of blood clots, for AIS patients has been shown in clinical trials to be safe up to 8 hours after symptom onset. Recent trials utilizing advanced imaging to identify patients with large vessel occlusions amenable to intra-arterial thrombectomy (IAT) have shown superiority endovascular therapy over medical therapy to result in improved patient functional outcomes. Pilot data utilizing the ADAPT (A Direct Aspiration First Pass Technique) approach has shown superior technical results with similar functional outcomes while lowering procedure time and device costs versus traditional stent retriever as a first line therapy approaches.
For more information about this trial, please contact Alicia Drew, Director, Research and Physician Services at Radiology Imaging Associates.
If you would like to explore more clinical information about this trial, please see the trial page on ClinicalTrials.gov
You Might Also Enjoy...
This is a prospective study to compare the safety and efficacy of treating small aneurysms.
Safety and Effectiveness of the Treatment of Wide-Neck, Intracranial, Saccular Aneurysms with the Next Generation Neuroform Stent System.
StrokeNet, developed by NIH, is the new structure for federal funding of all aspects of stroke research including prevention, acute treatment, and recovery / rehabilitation.
RIA has a rich history of participation in clinical research and innovation dating back to the 1980s. Many of our physicians believe it is important to contribute to science and advance medicine.
The full name of this study is: Barrel™: Study of the Reverse Medical Barrel™ Vascular Reconstruction Device for Adjunctive Treatment to Embolic Coils for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms.
This is a prospective, multi-center study of patients treated in accordance with the cleared indications for the Penumbra SMART CoilTM System (SMART), Penumbra Coil 400TM (PC 400), and Penumbra Occlusion DeviceTM (POD).